Third Dose a Charm in Israel? Door-to-Door 'Goons'; Cervids Catch COVID, Too! A daily roundup of news on COVID-19 and the rest of medicine Jul 30, 2021
Acne Takes a Toll on Women's Mental Health, Quality of Life Almost half reported self-consciousness, adverse effects on professional, social, personal lives Jul 28, 2021
Rates of Serious Infection Differ Among Psoriasis Therapies Low overall rate, small differences versus etanercept reference, large French study showed Jul 22, 2021
FDA Approves IVIG for Dermatomyositis Octagam 10% lands indication for adults following results of ProDERM trial Jul 20, 2021
Shingles Risk Slashed in IBD Patients After Vaccine Study found certain medications also showed lower incidence rates Jul 20, 2021
Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
COVID Surges Emerge; FDA Warns About Chantix; Lions, Tigers, Bears Get Vaxxed A daily roundup of news on COVID-19 and the rest of medicine Jul 06, 2021
Target TNF or IL-12/23 in Psoriatic Arthritis? Both TNF inhibitors and ustekinumab were effective in real-world use Jun 30, 2021
Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survival News, features, and commentary about cancer-related issues Jun 16, 2021
Physician Organizations Challenge PA Name Change The AMA and AOA release statements against the rebrand Jun 09, 2021
Adjuvant Anti-PD-1 Misses on OS in High-Risk Melanoma But pembrolizumab topped active controls for relapse-free survival Jun 07, 2021
Lymph Node Findings on PET: Cancer or COVID Vaccine? Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
Bad Day Sunshine: Benzene Found in Many Sun Care Products Valisure also detected the carcinogen in hand sanitizers earlier this year May 26, 2021
Methotrexate Impairs COVID Vax Response Can extra vaccine doses or discontinuing drug benefit patients with immune-mediated diseases? May 25, 2021
Unhealthy Quest for Lighter Skin Fuels Bleaching Epidemic Breaking the centuries-old cycle of myths about skin color May 25, 2021
Plaque Psoriasis Drug Shows Promise for Psoriatic Arthritis Monoclonal antibody targets the IL-23 p19 subunit May 20, 2021
Novel Immunotherapy Boosts Melanoma Outcomes Adding LAG-3 checkpoint inhibitor to nivolumab extended PFS in patients with advanced disease May 19, 2021
For Safety, One Biologic a Winner in Psoriasis, Psoriatic Arthritis Lower hospitalization rates compared with other biologics or small molecule therapies May 19, 2021
Rituximab Tops Mycophenolate Mofetil for Pemphigus Vulgaris Sustained complete response rate four times higher with anti-CD20 antibody May 19, 2021
Is This the Most TikTok'd COVID Vaccine Side Effect? Dermatologists say there's no issue: 'Happy filling, happy vaccinating' May 12, 2021
No Clarity for Role of Laser Therapy in Vulvar Lichen Sclerosus Mixed results from two small randomized clinical trials May 10, 2021
Doubling Down on Immunotherapy in Advanced Melanoma Checkpoint inhibitor combo active after upfront anti-PD-1/L1 therapy May 09, 2021
Another COVID-19 Side Effect: 'Zoom Dysmorphia' As people spend more time on camera, many of them like themselves less and less May 06, 2021
First Detailed Look at COVID Vaccine Skin Reactions Mostly mild, self-limiting reactions and no serious adverse reactions May 05, 2021
Rapid Improvement in Atopic Dermatitis With New JAK1 Inhibitor Plus: First-in-class drug shows promise in AD, BTK inhibitor active in pemphigus May 03, 2021
Topical JAK Inhibitor Shows Promise in Vitiligo Half of patients had 90% improvement after 2 years of treatment Apr 30, 2021
High Rate of Hyperhidrosis Relief With Topical Agent Benefit for 86% of patients treated with sofpironium bromide Apr 29, 2021
Rapid Improvement in Atopic Dermatitis With Topical JAK Inhibitor Disease activity index improved as early as week 1 with delgocitinib cream Apr 27, 2021
Significant Improvement in Hand Eczema With Pan-JAK Inhibitor Disease activity indicators reduced, no safety signals with gusacitinib versus placebo Apr 26, 2021
Drug 'TYKs' All the Boxes in Two Plaque Psoriasis Trials Significantly higher response rates with TYK2 inhibitor deucravacitinib versus apremilast Apr 25, 2021
Big Win in Psoriasis for Dual IL-17A/17F Inhibitor Significant differences in clearance with bimekizumab vs secukinumab at all time points Apr 23, 2021
Nivolumab Alone Prevails in Resected Melanoma Adding ipilimumab in adjuvant setting failed to improve relapse-free survival Apr 11, 2021
For Enthesitis in Psoriatic Arthritis, Target IL-23 Targeted agent provides relief for many PsA patients Apr 08, 2021
COVID Triggers Novel Infectious Skin Condition in Teen Mild case led to unusual effects a week later Apr 07, 2021
JAK Inhibitor Promising in Psoriatic Arthritis Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
A Win for Adjuvant Immunotherapy in Esophageal Cancer And other highlights from the Society of Surgical Oncology's virtual 2021 meeting Mar 31, 2021
Don't Stop Taltz in Psoriatic Arthritis Significantly more patients relapsed, and more quickly, after withdrawal Mar 10, 2021
Using the Skin Microbiome to Control Atopic Dermatitis Bacteria-based therapy shows promise in proof-of-concept trial Mar 01, 2021
